APA (7th ed.) Citation

Antoni, D., Burckel, H., & Noel, G. (2020). Effects of ALK inhibitors (PF-02341066 and PF-06463922) with radiotherapy in EML4 – ALK fusion positive (H2228 and 185IG) and negative (A549) experimental lung cancer cell lines. International Journal of Radiation Oncology, Biology, Physics, 108(3), e507. https://doi.org/10.1016/j.ijrobp.2020.07.1599

Chicago Style (17th ed.) Citation

Antoni, D.N, H. Burckel, and G. Noel. "Effects of ALK Inhibitors (PF-02341066 and PF-06463922) with Radiotherapy in EML4 – ALK Fusion Positive (H2228 and 185IG) and Negative (A549) Experimental Lung Cancer Cell Lines." International Journal of Radiation Oncology, Biology, Physics 108, no. 3 (2020): e507. https://doi.org/10.1016/j.ijrobp.2020.07.1599.

MLA (9th ed.) Citation

Antoni, D.N, et al. "Effects of ALK Inhibitors (PF-02341066 and PF-06463922) with Radiotherapy in EML4 – ALK Fusion Positive (H2228 and 185IG) and Negative (A549) Experimental Lung Cancer Cell Lines." International Journal of Radiation Oncology, Biology, Physics, vol. 108, no. 3, 2020, p. e507, https://doi.org/10.1016/j.ijrobp.2020.07.1599.